{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T02:52:58Z","timestamp":1771210378835,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":1532,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1038\/s41374-018-0101-0","type":"journal-article","created":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T12:39:25Z","timestamp":1535114365000},"page":"1465-1477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Ursodeoxycholate inhibits mast cell activation and reverses biliary injury and fibrosis in Mdr2\u2212\/\u2212 mice and human primary sclerosing cholangitis"],"prefix":"10.1016","volume":"98","author":[{"given":"Fanyin","family":"Meng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsey","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Hargrove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Demieville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taronish","family":"Madeka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allen","family":"Karstens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Chappell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianfranco","family":"Alpini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amelia","family":"Sybenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Invernizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Bernuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"DeMorrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Francis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/s41374-018-0101-0_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-0035-1571274","article-title":"New therapeutic strategies for primary sclerosing cholangitis","volume":"36","author":"Williamson","year":"2016","journal-title":"Semin Liver Dis"},{"issue":"Suppl 2","key":"10.1038\/s41374-018-0101-0_bib2","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1159\/000440827","article-title":"Therapy of primary sclerosing cholangitis\u2014today and tomorrow","volume":"33","author":"Halilbasic","year":"2015","journal-title":"Dig Dis"},{"key":"10.1038\/s41374-018-0101-0_bib3","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jhep.2005.06.025","article-title":"Mdr2 (Abcb4)\u2212\/\u2212 mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes","volume":"43","author":"Popov","year":"2005","journal-title":"J Hepatol"},{"key":"10.1038\/s41374-018-0101-0_bib4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-2006-960172","article-title":"MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes","volume":"27","author":"Trauner","year":"2007","journal-title":"Semin Liver Dis"},{"key":"10.1038\/s41374-018-0101-0_bib5","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/hep.28704","article-title":"Inhibition of mast cell-secreted histamine decreases biliary proliferation and fibrosis in primary sclerosing cholangitis Mdr2\u2212\/\u2212 mice","volume":"64","author":"Jones","year":"2016","journal-title":"Hepatology"},{"key":"10.1038\/s41374-018-0101-0_bib6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.iac.2006.05.007","article-title":"Mast cells: not only in allergy","volume":"26","author":"Bachelet","year":"2006","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1038\/s41374-018-0101-0_bib7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/eji.200838899","article-title":"Our perception of the mast cell from Paul Ehrlich to now","volume":"39","author":"Beaven","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1038\/s41374-018-0101-0_bib8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1067\/mai.2003.60","article-title":"Mast cells: beyond IgE","volume":"111","author":"Boyce","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1038\/s41374-018-0101-0_bib9","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/labinvest.2014.129","article-title":"Inhibition of mast cell-derived histamine secretion by cromolyn sodium treatment decreases biliary hyperplasia in cholestatic rodents","volume":"94","author":"Kennedy","year":"2014","journal-title":"Lab Invest"},{"issue":"6","key":"10.1038\/s41374-018-0101-0_bib10","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1002\/hep.29079","article-title":"Bile duct ligation-induced biliary hyperplasia, hepatic injury, and fibrosis are reduced in mast cell-deficient KitW-sh mice","volume":"65","author":"Hargrove","year":"2017","journal-title":"Hepatology"},{"key":"10.1038\/s41374-018-0101-0_bib11","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jhep.2015.02.023","article-title":"New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR, and beyond","volume":"62","author":"Beuers","year":"2015","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"10.1038\/s41374-018-0101-0_bib12","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1111\/liv.13306","article-title":"Management of cholestatic disease in 2017","volume":"37","author":"de Vries","year":"2017","journal-title":"Liver Int"},{"key":"10.1038\/s41374-018-0101-0_bib13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bpg.2011.02.001","article-title":"Fibrosis in autoimmune and cholestatic liver disease","volume":"25","author":"Penz-Osterreicher","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1038\/s41374-018-0101-0_bib14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1471-230X-13-155","article-title":"Liver protective effect of ursodeoxycholic acid includes regulation of ADAM17 activity","volume":"13","author":"Buryova","year":"2013","journal-title":"BMC Gastroenterol"},{"key":"10.1038\/s41374-018-0101-0_bib15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases","volume":"51","author":"European Association for the Study of the L.","year":"2009","journal-title":"J Hepatol"},{"key":"10.1038\/s41374-018-0101-0_bib16","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1053\/gast.2002.35948","article-title":"Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles","volume":"123","author":"Fickert","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1038\/s41374-018-0101-0_bib17","doi-asserted-by":"crossref","first-page":"G813","DOI":"10.1152\/ajpgi.00188.2014","article-title":"Knockout of histidine decarboxylase decreases bile duct ligation-induced biliary hyperplasia via downregulation of the histidine decarboxylase\/VEGF axis through PKA-ERK1\/2 signaling","volume":"307","author":"Graf","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1038\/s41374-018-0101-0_bib18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fimmu.2012.00119","article-title":"Mast cell chemotaxis\u2014chemoattractants and signaling pathways","volume":"3","author":"Halova","year":"2012","journal-title":"Front Immunol"},{"key":"10.1038\/s41374-018-0101-0_bib19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0016-5085(99)70242-8","article-title":"Bile acid feeding induces cholangiocyte proliferation and secretion: evidence for bile acid-regulated ductal secretion","volume":"116","author":"Alpini","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1038\/s41374-018-0101-0_bib20","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1053\/jhep.2001.28884","article-title":"Bile acid feeding increased proliferative activity and apical bile acid transporter expression in both small and large rat cholangiocytes","volume":"34","author":"Alpini","year":"2001","journal-title":"Hepatology"},{"key":"10.1038\/s41374-018-0101-0_bib21","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1053\/jhep.2002.32712","article-title":"Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha","volume":"35","author":"Alpini","year":"2002","journal-title":"Hepatology"},{"key":"10.1038\/s41374-018-0101-0_bib22","first-page":"225","article-title":"Activated hepatic stellate cells in liver cirrhosis. A morphologic and morphometrical study","volume":"109","author":"Carpino","year":"2004","journal-title":"Ital J Anat Embryol"},{"key":"10.1038\/s41374-018-0101-0_bib23","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.dld.2004.11.009","article-title":"Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation","volume":"37","author":"Carpino","year":"2005","journal-title":"Dig Liver Dis"},{"key":"10.1038\/s41374-018-0101-0_bib24","first-page":"1175","article-title":"Intrahepatic mast cells in chronic liver diseases","volume":"22","author":"Farrell","year":"1995","journal-title":"Hepatology"},{"key":"10.1038\/s41374-018-0101-0_bib25","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.dld.2010.02.016","article-title":"A review of mast cells and liver disease: what have we learned?","volume":"42","author":"Francis","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1038\/s41374-018-0101-0_bib26","first-page":"138","article-title":"Mast cells, disease and gastrointestinal cancer: A comprehensive review of recent findings","volume":"1","author":"Hodges","year":"2012","journal-title":"Transl Gastrointest Cancer"},{"key":"10.1038\/s41374-018-0101-0_bib27","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.1365-2982.2010.01510.x","article-title":"Effect of ursodeoxycholic acid on inflammatory infiltrate in gallbladder muscle of cholesterol gallstone patients","volume":"22","author":"Carotti","year":"2010","journal-title":"Neurogastroenterol Motil"},{"key":"10.1038\/s41374-018-0101-0_bib28","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1211\/0022357011775839","article-title":"Taurocholic acid-induced secretion in normal and cystic fibrosis mouse ileum","volume":"53","author":"Hardcastle","year":"2001","journal-title":"J Pharm Pharmacol"},{"key":"10.1038\/s41374-018-0101-0_bib29","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2353\/ajpath.2006.050126","article-title":"Ca2+-dependent cytoprotective effects of ursodeoxycholic and tauroursodeoxycholic acid on the biliary epithelium in a rat model of cholestasis and loss of bile ducts","volume":"168","author":"Marzioni","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1038\/s41374-018-0101-0_bib30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1478-3231.2005.01210.x","article-title":"Rat liver fibrosis regresses better with pegylated interferon alpha2b and ursodeoxycholic acid treatments than spontaneous recovery","volume":"26","author":"Tasci","year":"2006","journal-title":"Liver Int"},{"key":"10.1038\/s41374-018-0101-0_bib31","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s00535-015-1104-x","article-title":"Beneficial effects of combined ursodeoxycholic acid and angiotensin-II type 1 receptor blocker on hepatic fibrogenesis in a rat model of nonalcoholic steatohepatitis","volume":"51","author":"Namisaki","year":"2016","journal-title":"J Gastroenterol"},{"key":"10.1038\/s41374-018-0101-0_bib32","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.dld.2015.09.002","article-title":"Protective effects of tranilast on oxazolone-induced rat colitis through a mast cell-dependent pathway","volume":"48","author":"Chu","year":"2016","journal-title":"Dig Liver Dis"},{"key":"10.1038\/s41374-018-0101-0_bib33","doi-asserted-by":"crossref","first-page":"e75262","DOI":"10.1371\/journal.pone.0075262","article-title":"Mast cell stabilization alleviates acute lung injury after orthotopic autologous liver transplantation in rats by downregulating inflammation","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1038\/s41374-018-0101-0_bib34","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1042\/CS20080075","article-title":"Chronic administration of ursodeoxycholic acid decreases portal pressure in rats with biliary cirrhosis","volume":"116","author":"Yang","year":"2009","journal-title":"Clin Sci (Lond)"},{"key":"10.1038\/s41374-018-0101-0_bib35","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/hep.24047","article-title":"Combination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct-ligated rats and human hepatic cells","volume":"53","author":"He","year":"2011","journal-title":"Hepatology"},{"key":"10.1038\/s41374-018-0101-0_bib36","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/hep.25531","article-title":"Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease","volume":"55","author":"Pathil","year":"2012","journal-title":"Hepatology"},{"key":"10.1038\/s41374-018-0101-0_bib37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jhep.2012.08.002","article-title":"Bile acid transporters and regulatory nuclear receptors in the liver and beyond","volume":"58","author":"Halilbasic","year":"2013","journal-title":"J Hepatol"},{"key":"10.1038\/s41374-018-0101-0_bib38","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","article-title":"Identification of a nuclear receptor for bile acids","volume":"284","author":"Makishima","year":"1999","journal-title":"Science"},{"key":"10.1038\/s41374-018-0101-0_bib39","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.jhep.2014.12.034","article-title":"Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity","volume":"62","author":"Mueller","year":"2015","journal-title":"J Hepatol"},{"key":"10.1038\/s41374-018-0101-0_bib40","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/hep.20653","article-title":"Secretin activation of the apical Na+-dependent bile acid transporter is associated with cholehepatic shunting in rats","volume":"41","author":"Alpini","year":"2005","journal-title":"Hepatology"},{"issue":"Suppl 3","key":"10.1038\/s41374-018-0101-0_bib41","first-page":"S420","article-title":"Novel interaction of bile acid and neural signaling in the regulation of cholangiocyte function","volume":"37","author":"Fava","year":"2007","journal-title":"Hepatol Res"},{"key":"10.1038\/s41374-018-0101-0_bib42","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/0016-5085(91)90024-F","article-title":"Activation of mast cells by bile acids","volume":"101","author":"Quist","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1038\/s41374-018-0101-0_bib43","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/hep.27973","article-title":"Pharmacological inhibition of apical sodium-dependent bile acid transporter changes bile composition and blocks progression of sclerosing cholangitis in multidrug resistance-2 knockout mice","volume":"63","author":"Miethke","year":"2016","journal-title":"Hepatology"},{"key":"10.1038\/s41374-018-0101-0_bib44","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jhep.2017.05.009","article-title":"nor-Ursodeoxycholic acid improves cholestasis in primary sclerosing cholangitis","volume":"67","author":"Fickert","year":"2017","journal-title":"J Hepatol"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41374-018-0101-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41374-018-0101-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722010820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722010820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41374-018-0101-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:35:29Z","timestamp":1758396929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722010820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0023683722010820"],"URL":"https:\/\/doi.org\/10.1038\/s41374-018-0101-0","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ursodeoxycholate inhibits mast cell activation and reverses biliary injury and fibrosis in Mdr2\u2212\/\u2212 mice and human primary sclerosing cholangitis","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41374-018-0101-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}